Anzeige
Mehr »
Donnerstag, 15.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von MedCity News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
06.05.Eli Lilly Turns to Alchemab to Add Another AI-Discovered ALS Drug Prospect
06.05.How Healthcare Employers Can Do More To Help Providers Manage Payer Frustration
06.05.A Reality Check on SDOH: Challenges We Can't Ignore
06.05.Eliminating Blind Spots in the Patient Journey
06.05.What Is the Economic Impact of Medicaid Work Requirements?
05.05.J&J Gene Therapy for Rare, Progressive Vision-Loss Disorder Fails Phase 3 Test
05.05.The Dementia Diagnosis Gap Is Wider Than We Think
05.05.Acuity-driven Care - Leveraging Multi-level Monitoring for Complex Needs
05.05.What Do Early Stage Life Science Companies Need to Grow?
05.05.Are Therapy-Bots Really Our Best Chance At Solving Population Mental Health?
04.05.The Policy Trends the Business Group on Health Is Watching
04.05.Hospitals' Costs Are Soaring: 3 Stats to Know
04.05.So What's the Deal with ICHRA?
04.05.Investor Caution Leads to Dip in Biotech Financings, GlobalData Report Shows
02.05.DOJ Sues MA Insurers, Brokers Over Alleged Kickbacks
02.05.FDA Pushes Out Decision for Cytokinetics Heart Drug to Review Proposed Safety Plan
02.05.AI in Clinical Settings: Balancing Innovation, Patient Care, and Personalized Medicine
02.05.3 Ways Companies Can Make Healthcare More Affordable
02.05.Time is Running Out to Join the Healthcare Innovation Conversation at INVEST 2025
02.05.How Imagine360 Saved this Employer 19% Compared to Traditional Health Plans
02.05.Seca Launches First Portable Body Composition Scan for Primary Care
01.05.Debunked Episode 15: How Did UnitedHealth Fail to Anticipate a Rise in Medical Utilization Costs?
01.05.FDA Nod for J&J Autoimmune Drug is First of Potentially Many for the Projected Blockbuster Product
01.05.The ICHRA Moment Is Here - Are You Ready for It?
01.05.Expanding Support for Mail-Based Naloxone Delivery